skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin

Authors:
; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1497145
Resource Type:
Journal Article
Journal Name:
Science Translational Medicine
Additional Journal Information:
Journal Volume: 6; Journal Issue: 263; Journal ID: ISSN 1946-6234
Publisher:
AAAS
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Xia, Y., Liu, Y. -L., Xie, Y., Zhu, W., Guerra, F., Shen, S., Yeddula, N., Fischer, W., Low, W., Zhou, X., Zhang, Y., Oldfield, E., and Verma, I. M. A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin. United States: N. p., 2014. Web. doi:10.1126/scitranslmed.3010382.
Xia, Y., Liu, Y. -L., Xie, Y., Zhu, W., Guerra, F., Shen, S., Yeddula, N., Fischer, W., Low, W., Zhou, X., Zhang, Y., Oldfield, E., & Verma, I. M. A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin. United States. doi:10.1126/scitranslmed.3010382.
Xia, Y., Liu, Y. -L., Xie, Y., Zhu, W., Guerra, F., Shen, S., Yeddula, N., Fischer, W., Low, W., Zhou, X., Zhang, Y., Oldfield, E., and Verma, I. M. Wed . "A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin". United States. doi:10.1126/scitranslmed.3010382.
@article{osti_1497145,
title = {A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin},
author = {Xia, Y. and Liu, Y. -L. and Xie, Y. and Zhu, W. and Guerra, F. and Shen, S. and Yeddula, N. and Fischer, W. and Low, W. and Zhou, X. and Zhang, Y. and Oldfield, E. and Verma, I. M.},
abstractNote = {},
doi = {10.1126/scitranslmed.3010382},
journal = {Science Translational Medicine},
issn = {1946-6234},
number = 263,
volume = 6,
place = {United States},
year = {2014},
month = {11}
}

Works referenced in this record:

Targeting protein prenylation for cancer therapy
journal, October 2011

  • Berndt, Norbert; Hamilton, Andrew D.; Sebti, Saïd M.
  • Nature Reviews Cancer, Vol. 11, Issue 11
  • DOI: 10.1038/nrc3151

Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans
journal, October 2009

  • Morck, C.; Olsen, L.; Kurth, C.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 43
  • DOI: 10.1073/pnas.0907117106

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
journal, February 2011

  • Guo, J. Y.; Chen, H. -Y.; Mathew, R.
  • Genes & Development, Vol. 25, Issue 5
  • DOI: 10.1101/gad.2016311

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
journal, February 2009

  • Gnant, Michael; Mlineritsch, Brigitte; Schippinger, Walter
  • New England Journal of Medicine, Vol. 360, Issue 7
  • DOI: 10.1056/NEJMoa0806285

Geranylgeranyltransferase I Inhibitors Target RalB To Inhibit Anchorage-Dependent Growth and Induce Apoptosis and RalA To Inhibit Anchorage-Independent Growth
journal, September 2007

  • Falsetti, S. C.; Wang, D. -a.; Peng, H.
  • Molecular and Cellular Biology, Vol. 27, Issue 22
  • DOI: 10.1128/MCB.00057-07

Targeting RAS signalling pathways in cancer therapy
journal, January 2003

  • Downward, Julian
  • Nature Reviews Cancer, Vol. 3, Issue 1
  • DOI: 10.1038/nrc969

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis
journal, March 2013

  • Zhang, Yonghui; Zhu, Wei; Liu, Yi-Liang
  • ACS Medicinal Chemistry Letters, Vol. 4, Issue 4
  • DOI: 10.1021/ml4000436

Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
journal, November 2013

  • Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.
  • Nature, Vol. 503, Issue 7477
  • DOI: 10.1038/nature12796

RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival
journal, October 2006


HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes
journal, July 2006

  • Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek
  • Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8
  • DOI: 10.1107/S0907444906019949

Dislodgment and Accelerated Degradation of Ras
journal, February 1998

  • Haklai, Roni; Weisz, Mali Gana; Elad, Galit
  • Biochemistry, Vol. 37, Issue 5
  • DOI: 10.1021/bi972032d


journal, June 2008


Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
journal, October 2010

  • Kwak, Eunice L.; Bang, Yung-Jue; Camidge, D. Ross
  • New England Journal of Medicine, Vol. 363, Issue 18
  • DOI: 10.1056/NEJMoa1006448

GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer
journal, May 2007

  • Sjogren, Anna-Karin M.; Andersson, Karin M. E.; Liu, Meng
  • Journal of Clinical Investigation, Vol. 117, Issue 5
  • DOI: 10.1172/JCI30868

Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy
journal, January 2010

  • Verfaillie, Tom; Salazar, Maria; Velasco, Guillermo
  • International Journal of Cell Biology, Vol. 2010
  • DOI: 10.1155/2010/930509

Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

p21ras is modified by a farnesyl isoprenoid.
journal, November 1989

  • Casey, P. J.; Solski, P. A.; Der, C. J.
  • Proceedings of the National Academy of Sciences, Vol. 86, Issue 21
  • DOI: 10.1073/pnas.86.21.8323

Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer
journal, March 2010

  • Liu, M.; Sjogren, A. -K. M.; Karlsson, C.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 14
  • DOI: 10.1073/pnas.0908396107

The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis
journal, April 2008


Thermodynamics of Bisphosphonates Binding to Human Bone: A Two-Site Model
journal, June 2009

  • Mukherjee, Sujoy; Huang, Cancan; Guerra, Francisco
  • Journal of the American Chemical Society, Vol. 131, Issue 24
  • DOI: 10.1021/ja902895p

Aborted Autophagy and Nonapoptotic Death Induced by Farnesyl Transferase Inhibitor and Lovastatin
journal, January 2011

  • Wojtkowiak, Jonathan W.; Sane, Komal M.; Kleinman, Miriam
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 337, Issue 1
  • DOI: 10.1124/jpet.110.174573

Bisphosphonates Induce Autophagy by Depleting Geranylgeranyl Diphosphate
journal, February 2011

  • Wasko, Brian M.; Dudakovic, Amel; Hohl, Raymond J.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 337, Issue 2
  • DOI: 10.1124/jpet.110.175521

Deconvoluting the context-dependent role for autophagy in cancer
journal, April 2012

  • White, Eileen
  • Nature Reviews Cancer, Vol. 12, Issue 6
  • DOI: 10.1038/nrc3262

HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression
journal, June 2008

  • Chen, Jui-Ching; Wu, Mei-Lin; Huang, Kuo-Chin
  • Cardiovascular Research, Vol. 80, Issue 1
  • DOI: 10.1093/cvr/cvn160

Autophagy as a target for anticancer therapy
journal, May 2011

  • Janku, Filip; McConkey, David J.; Hong, David S.
  • Nature Reviews Clinical Oncology, Vol. 8, Issue 9
  • DOI: 10.1038/nrclinonc.2011.71

Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
journal, February 2012

  • Xia, Yifeng; Yeddula, Narayana; Leblanc, Mathias
  • Nature Cell Biology, Vol. 14, Issue 3
  • DOI: 10.1038/ncb2428

Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
journal, May 2013

  • Zimmermann, Gunther; Papke, Björn; Ismail, Shehab
  • Nature, Vol. 497, Issue 7451
  • DOI: 10.1038/nature12205

p53 status determines the role of autophagy in pancreatic tumour development
journal, December 2013

  • Rosenfeldt, Mathias T.; O’Prey, Jim; Morton, Jennifer P.
  • Nature, Vol. 504, Issue 7479
  • DOI: 10.1038/nature12865

Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation
journal, April 2009

  • Zhang, Yonghui; Cao, Rong; Yin, Fenglin
  • Journal of the American Chemical Society, Vol. 131, Issue 14
  • DOI: 10.1021/ja808285e

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells
journal, March 2006


Molecular Characterization of a Novel Geranylgeranyl Pyrophosphate Synthase from Plasmodium Parasites
journal, November 2010

  • Artz, Jennifer D.; Wernimont, Amy K.; Dunford, James E.
  • Journal of Biological Chemistry, Vol. 286, Issue 5
  • DOI: 10.1074/jbc.M109.027235

Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
journal, August 2013

  • Hatzivassiliou, Georgia; Haling, Jacob R.; Chen, Huifen
  • Nature, Vol. 501, Issue 7466
  • DOI: 10.1038/nature12441

Biodistribution and Plasma Protein Binding of Zoledronic Acid
journal, July 2008

  • Weiss, H. Markus; Pfaar, Ulrike; Schweitzer, Alain
  • Drug Metabolism and Disposition, Vol. 36, Issue 10
  • DOI: 10.1124/dmd.108.021071

Harnessing synthetic lethal interactions in anticancer drug discovery
journal, April 2011

  • Chan, Denise A.; Giaccia, Amato J.
  • Nature Reviews Drug Discovery, Vol. 10, Issue 5
  • DOI: 10.1038/nrd3374

Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
journal, March 2009


Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.
journal, April 1990

  • Jackson, J. H.; Cochrane, C. G.; Bourne, J. R.
  • Proceedings of the National Academy of Sciences, Vol. 87, Issue 8
  • DOI: 10.1073/pnas.87.8.3042

Bisphosphonates: A review of their pharmacokinetic properties
journal, February 1996



journal, June 2009


Pancreatic cancers require autophagy for tumor growth
journal, March 2011

  • Yang, S.; Wang, X.; Contino, G.
  • Genes & Development, Vol. 25, Issue 7
  • DOI: 10.1101/gad.2016111

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer
journal, September 2009


KRAS Mutations in Non-Small Cell Lung Cancer
journal, April 2009

  • Riely, G. J.; Marks, J.; Pao, W.
  • Proceedings of the American Thoracic Society, Vol. 6, Issue 2
  • DOI: 10.1513/pats.200809-107LC

Requirement for Rac1 in a K-ras–Induced Lung Cancer in the Mouse
journal, September 2007


    Works referencing / citing this record:

    Polyoxomolybdate Bisphosphonate Heterometallic Complexes: Synthesis, Structure, and Activity on a Breast Cancer Cell Line
    journal, June 2015

    • Saad, Ali; Zhu, Wei; Rousseau, Guillaume
    • Chemistry - A European Journal, Vol. 21, Issue 29
    • DOI: 10.1002/chem.201406565